March 29, 2023
Unites Complementary Businesses with the Most Trusted Brands and Diversified Capabilities to Create a Premier Dedicated Manufacturer of Respiratory and Anesthesia Consumables
Enables SunMed to Better Serve Customers by Providing More Comprehensive Portfolio of the Highest-Quality Products
Supports More Reliable Supply, Improved Patient Outcomes and Broader Global Reach
GRAND RAPIDS, Mich.–( BUSINESS WIRE )–SunMed, a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care, today announced it has entered into a definitive agreement with Vyaire Medical, under which SunMed will acquire Vyaire’s business unit that manufactures and markets respiratory and anesthesia consumables focused on airway management and operative care. The combined business, as a leading manufacturer wholly dedicated to this market, will be well positioned to enhance innovation, ensure reliable and predictable product supply for customers and be a one-stop source for the highest-quality consumable respiratory and anesthesia medical products to ensure the best outcomes for patients. “This combination represents an exciting growth opportunity for SunMed that will strengthen our already robust core consumables business and further differentiate our ability to meet our customers’ needs,” said Hank Struik, CEO of SunMed. “The transaction brings together two like-minded teams who share a deep commitment to quality, reliability and continuous innovation as trusted partners to healthcare professionals. Vyaire’s respiratory and anesthesia business brings an impressive manufacturing platform, which will add to our already deep North American manufacturing presence, a strong product pipeline with some of the most trusted brands in the market and deep relationships with customers and distributors. This transaction will enable us to deliver even greater innovation, predictability and value for our customers, their practitioners and their patients – all on an expanded global basis.”
Philip Zaorski, Partner at Frazier Healthcare Partners, which acquired a majority ownership stake in SunMed in 2021, said, “The combination of these two businesses represents an important step forward in our ambition to create the leading manufacturer of consumable respiratory and anesthesia medical products. We believe there are significant opportunities for further growth and investment. We look forward to working with the combined teams to deliver on this enormous potential.”
The respiratory and anesthesia consumables business of Vyaire encompasses leading airway management and operative care technology, including AirLife™ oxygen therapy and Vital Signs™ anesthesia circuits. Vyaire brings a diversified range of high-quality, easy-to-use respiratory and anesthesia consumable products that are respected by clinicians and patients across the globe. Compelling Strategic Benefits
Strengthens Respiratory and Anesthesia Portfolio: This deal combines two companies that for decades have pioneered the most trusted brands and set the standard for care. SunMed’s brands include Salter Labs®, Ethox Medical™ and Ventlab™, while Vyaire’s complementary product portfolio includes premier brands with strong customer loyalty such as AirLife™ and Vital Signs™. Together, the combined suite of anesthesia and respiratory consumable products will allow the Company to provide a more comprehensive offering of products for practitioners, from first responders to hospitals and home care, with a continued focus on safety, patient comfort and clinical performance. Improves Supply Chain Resiliency: With the addition of Vyaire’s North American manufacturing facility for respiratory and anesthesia consumables, SunMed will have even greater proximity to customers and have the ability to mitigate disruptive supply chain environments, ensuring fast, accurate and reliable product delivery. Enhances Manufacturing Capabilities: As a combined company, SunMed will enhance its position as one of the most capable converters of plastic materials into high-quality, medical-grade devices with world-class molding, extrusion and assembly expertise. SunMed will have a scaled platform spanning over 250,000 square feet of manufacturing space. Extends Global Reach: SunMed will be positioned to serve more customers across more markets with a stronger sales presence and broader distribution network globally. The combined company will have an expanded manufacturing footprint in North America, while integrating a facility in Shenzhen, China and increasing its global presence across more than a dozen countries. Bolsters Engineering Sophistication: As a result of the combination, the Company will expand its industry-leading engineering capabilities focused on innovation, quality and operational excellence and increase the total number of SunMed’s engineers to more than 150 worldwide. The proposed transaction, which is subject to customary closing conditions and regulatory approvals, is expected to be completed in the first half of this year. Vyaire will continue to fully manage its consumables business and products until the transaction is finalized. Goodwin Procter LLP is acting as legal counsel to SunMed. Jefferies is acting as financial advisor and Simpson Thacher & Bartlett LLP is acting as legal counsel to Vyaire. About SunMed
SunMed, headquartered in Grand Rapids, Michigan with manufacturing and distribution sites in the United States, Mexico, China and Europe, is a leading medical device manufacturer, offering one of the most comprehensive portfolios of consumable anesthesia and respiratory care products. SunMed’s product portfolio spans the continuum of care from first responders to hospitals and home care, with safety, patient comfort and clinical performance in mind. SunMed’s comprehensive portfolio of trusted respiratory care and anesthesia products include premier brands such as Salter Labs®, Ethox Medical™, Ventlab™ and Westmed™. Currently, SunMed has over 1 million square feet of manufacturing space, providing comprehensive expertise in all plastics materials and conversion—supported by a world-class Quality Management System. Frazier Healthcare Partners, a leading healthcare investment firm, acquired a majority ownership stake in SunMed in 2021. About Vyaire’s Respiratory Consumables Business
The respiratory and anesthesia consumables business of Vyaire, which Vyaire purchased from Becton Dickinson in 2018, encompasses leading airway management and operative care technology, including Vital Signs™ oxygen therapy and AirLife™ anesthesia circuits. Vyaire brings a diversified range of high-quality, easy to use respiratory and anesthesia consumable products that are respected by clinicians and patients across the globe. About Frazier Healthcare Partners
Founded in 1991, Frazier Healthcare Partners is a leading private equity firm focused exclusively on the healthcare sector. With over $7.0 billion in total capital raised, Frazier has invested in more than 200 companies with transaction types ranging from buyouts of profitable healthcare services companies to venture capital and company creation. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier has offices in Seattle, WA, and Menlo Park, CA, and invests broadly across the U.S., Canada, and Europe. For more information about Frazier Healthcare Partners, visit www.frazierhealthcare.com .

SunMed to Acquire Respiratory and Anesthesia Consumables Business of Vyaire Medical

The brands involved in the deal are AirLife oxygen therapy, SuperNO2VA nasal PAP ventilation, and Vital Signs anaesthesia circuits among others
Vyaire Medical produces and markets a range of respiratory and anaesthesia consumables. (Credit: Mockup Graphics on Unsplash)
US-based consumable medical devices maker SunMed has agreed to buy Vyaire Medical’s respiratory and anaesthesia consumables business unit. The financial terms of the deal were not disclosed. The consumables division of Vyaire Medical produces and markets a range of consumables with a focus on airway management and operative care. The brands involved in the deal are AirLife oxygen therapy, SuperNO2VA nasal PAP ventilation, and Vital Signs anaesthesia circuits among others. Vyaire Medical CEO Gaurav Agarwal said: “This divestiture allows Vyaire to focus on its industry-leading respiratory diagnostics and ventilation businesses and accelerate our strategic growth plans. “Uniting the industry-leading Vyaire consumables portfolio with SunMed’s compatible suite of products is a win-win for both companies, as well as customers and patients, and will enhance the potential for long-term growth of the combined consumables portfolio.”
SunMed said that post-acquisition, the enlarged entity will aim to increase innovation and maintain reliable and predictable product supply. The enlarged business is also expected to act as a one-stop source for the consumable respiratory and anaesthesia products, said the Frazier Healthcare Partners-backed firm. The deal will combine a range of consumables products from both companies to offer a broader portfolio of products for practitioners, first responders, hospitals, and home care. According to SunMed, the addition of Vyaire Medical’s North American facility will ensure fast, accurate and reliable product delivery. The combined entity will help enhance SunMed’s manufacturing capabilities. After the closing of the deal, SunMed will have a scaled platform spread across 250,000ft2 of manufacturing space. Additionally, the acquisition will enable the consumable medical devices maker to enter new markets with strong sales presence and boost its global distribution network. SunMed CEO Hank Struik said: “This combination represents an exciting growth opportunity for SunMed that will strengthen our already robust core consumables business and further differentiate our ability to meet our customers’ needs. “The transaction brings together two like-minded teams who share a deep commitment to quality, reliability and continuous innovation as trusted partners to healthcare professionals.”
Expected to close in the first half of this year, the deal is subject to customary conditions and regulatory approvals. Do you have interesting content to share with us? Enter your email address so we can get in touch. Related Article

SunMed to buy Vyaire’s respiratory and anaesthesia consumables unit

GRAND RAPIDS, Mich.--(BUSINESS WIRE)--SunMed, a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care, today announced it has entered into a definitive agreement with Vyaire Medical (“Vyaire”), under which SunMed will acquire Vyaire’s business unit that manufactures and markets respiratory and anesthesia consumables focused on airway management and operative care. The combined business, as a leading manufacturer wholly dedicated to

News provided by
Share this article
Share this article
CHICAGO, March 28, 2023 /PRNewswire/ -- Vyaire Medical today announced an agreement for the sale of the Vyaire consumables business to SunMed, a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care. The Vyaire consumables portfolio encompasses leading airway management and operative care technology, including well-known brands such as AirLife™ oxygen therapy, Vital Signs™ anesthesia circuits and SuperNO2VA™ nasal PAP ventilation. These established products offer a differentiated portfolio of products for patients. "This divestiture allows Vyaire to focus on its industry-leading respiratory diagnostics and ventilation businesses and accelerate our strategic growth plans," said Gaurav Agarwal, chief executive officer, Vyaire. "Uniting the industry-leading Vyaire consumables portfolio with SunMed's compatible suite of products is a win-win for both companies, as well as customers and patients, and will enhance the potential for long-term growth of the combined consumables portfolio." "We are extremely pleased with this transaction, which will empower Vyaire to focus squarely on its specialty in respiratory diagnostics and ventilation moving forward, cementing its position as a market leader in this space," said Steven Dyson, Partner at Apax. "We look forward to working with the Vyaire team on this exciting new chapter for the business." Upon completion of the transaction, the combined businesses will create a premier dedicated manufacturer of respiratory and anesthesia consumables. Together, these complementary product lines will enhance the overall product offering for SunMed's customers and patients globally. Terms of the agreement were not disclosed. Vyaire will continue to fully manage its consumables business and products until the transaction is finalized, with full support to customers, and will work to ensure continuity for partners and suppliers. The agreement is subject to antitrust regulatory clearance in the US. Pending such regulatory clearance and fulfillment of other conditions, Vyaire currently anticipates closing the transaction in the coming months. Vyaire remains committed to its mission to empower the global respiratory community to enrich patients' quality of breathing throughout their lives. About Vyaire Medical
Vyaire Medical Inc. is a global company focused exclusively on supporting breathing through every stage of life. Established from legacy brands with a 65-year history of pioneering breathing technology, the company's portfolio of integrated solutions is designed to enable, enhance and extend lives. At Vyaire, we pledge to advance innovation and evolve what's possible to ensure every breath is taken to its fullest. Headquartered in suburban Chicago, Vyaire is recognized, trusted and preferred by specialists throughout the respiratory community worldwide. SOURCE Vyaire Medical

08:00 EDT
Vyaire Medical to Sell Consumables Business to SunMed

The portfolio is comprised of airway management and operative care technology. Sam Brusco, Associate Editor03.28.23
Vyaire Medical has agreed to sell its Vyaire consumable businesses to SunMed , a North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care. Terms of the deal were not disclosed. The Vyaire consumables portfolio is comprised of airway management and operative care technology such as brands AirLife oxygen therapy, Vital Signs anesthesia circuits, and SuperNO2VA nasal PAP ventilation. "This divestiture allows Vyaire to focus on its industry-leading respiratory diagnostics and ventilation businesses and accelerate our strategic growth plans," Gaurav Agarwal, CEO of Vyaire told the press. "Uniting the industry-leading Vyaire consumables portfolio with SunMed's compatible suite of products is a win-win for both companies, as well as customers and patients, and will enhance the potential for long-term growth of the combined consumables portfolio." "We are extremely pleased with this transaction, which will empower Vyaire to focus squarely on its specialty in respiratory diagnostics and ventilation moving forward, cementing its position as a market leader in this space," said Steven Dyson, partner at Apax. "We look forward to working with the Vyaire team on this exciting new chapter for the business." After the transaction is completed, the combined businesses will form a dedicated manufacturer of respiratory and anesthesia consumables. Vyaire will fully manage its consumables business and products until the transaction is finalized. Trending

Vyaire to Sell Consumables Biz to SunMed

Genworks is dedicated to improving healthcare access in India by delivering better medical facilities and diagnostics while keeping healthcare affordable. It is providing relevant and affordable technology to providers in India and therefore improving clinical outcomes. The company was founded in 2015 and is based in Bangalore, India.

Genworks

In May , Vyaire Medical , a global company focused exclusively on supporting breathing through every stage of life , entered into an agreement with GenWorks Health , a healthcare solutions provider with 140 locations within India and a direct presence in 27 states .

Follow us on Facebook
Follow us on LinkedIn
Follow us on Instagram
Vyaire Medical Expands Presence in India with GenWorks Deal.

Automated develops interpretations of pulmonary function tests. It is producing a standardized evaluation of a patient's lung function.

ArtiQ

The Commission represents and upholds the interests of the EU as a whole, and is independent of national governments. It is headed by 28 Commissioners, one per EU country. The European Commission prepares legislation for adoption by the Council (representing the member countries) and the Parliament (representing the citizens). It administers the budget and the policy programmes (Agriculture, Fisheries, Research etc.) in cooperation with authorities in the member countries.

European Commission

Spirit AeroSystems is a producer of large aerostructures and components of the world's premier aircraft. Spirit AeroSystems designs and builds aerostructures for both commercial and defense customers. With headquarters in Wichita, Kansas, Spirit operates sites in North America, Europe, and Asia.

Spirit AeroSystems

Acelity

Smith & Nephew

GE Healthcare

GEO Specialty Chemicals

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Medical Devices

Conference Exhibitors

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

Health Monitoring & Diagnostics

Health IT 

Steven  Dyson

Arthur  Brothag

Private Equity

Acq - Fin

Vyaire Medical is a global medical device company and unified "breathing company," specializing in the respiratory diagnostics, ventilation, and anesthesia delivery and patient monitoring market segments.

Name	Work History	Title	Status
Gaurav Agarwal	Acelity, Smith & Nephew, GE Healthcare, and GEO Specialty Chemicals	Chief Executive Officer	Current
Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more

Name	Gaurav Agarwal	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Work History	Acelity, Smith & Nephew, GE Healthcare, and GEO Specialty Chemicals	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Title	Chief Executive Officer	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Status	Current	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more

Wells Fargo Success Story

Professional Services

Platform Overview

Vyaire Medical

Executives

Vyaire Medical Management Team

16 Team Members

This profile has not been claimed.

Discover the right solution for your team